is januvia glp 1 GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes Recent updates on GLP-1 agonists:

Discover the rising GLP-1 receptor market, projected to reach $156.71 billion by 2030, driven by weight loss and metabolic health advancements

Discover medical weight loss insurance coverage in New York for Wegovy, Zepbound, Ozempic, Mounjaro, semaglutide, tirzepatide, and GLP-1 medications

Learn about Acarbose for controlling glucose spikes today.

Stay active, energized, and maintain healthy weight management throughout the day.

Learn which medications show promise for MASLD/NASH, the clinical evidence, how they work to reduce liver fat, and how to access treatment through the NHS.

Learn how gum disease and diabetes are connected